DVL2 and lung cancer: Suppression of Dvl2 increased cisplatin sensitivity via inhibition of the Wnt/β-catenin pathway in lung cancer cells, and blocking Dvl2/Snail signaling suppressed metastasis and reversed chemoresistance in colorectal cancer cells (32, 33).